New Frameworks to Assess Value of Cancer Care: Strengths and Limitations

Confronted with the different clinical impacts of different treatments, the rising cost of cancer care, and the financial burden of high drug prices, several influential professional organizations have developed models with which to assess the clinical benefit and value of cancer treatment regimens. The goal is a system of valuing patient therapies that is aligned with the beneficial impact to the patient and society and that moves away from a fixed cost regardless of clinical circumstances.